表紙
市場調查報告書
商品編碼
1082996

膽紅素儀的全球市場:2022年∼2029年

Global Bilirubin Meters Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 160 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球膽紅素儀的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素的分析,未滿足需求,市場規模的轉變·預測,各種區分·地區/各主要國家的明細,競爭環境,主要企業簡介等資訊。

目錄

第1章 調查手法·調查範圍

第2章 市場定義和概要

第3章 摘要整理

第4章 市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業分析

  • 供應鏈分析
  • 價格分析
  • 未滿足需求

第6章 COVID-19分析

  • COVID-19:對市場的影響分析
  • COVID-19風暴中的價格動態
  • 供需頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商的策略性舉措
  • 總論

第7章 市場分析:各產品類型

  • 台式產品
  • 經皮產品
  • 其他

第8章 市場分析:各年齡層

  • 新生兒
  • 成人
  • 其他

第9章 市場分析:各適應症

  • 肝炎
  • 黃疸
  • 其他

第10章 市場分析:各終端用戶

  • 醫院
  • 診所
  • 診斷中心
  • 其他

第11章 市場分析:各地區

  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第12章 競爭情形

  • 主要的展開·策略
  • 企業佔有率分析
  • 產品基準
  • 關注的主要企業清單

第13章 企業簡介

  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Dragerwerk AG Co. KGaA
  • Mennen Medical Ltd
  • Natus Medical Incorporated
  • Avi healthcare Pvt. Ltd.
  • Ningbo David Medical Device Co. Ltd.
  • Micro Lab Instruments
  • Zhengzhou Dison Instrument And Meter Co., Ltd
  • Delta Medical International Ltd

第14章 全球膽紅素儀市場:DataM

目錄
Product Code: DMMD5378

Market - Overview

The global bilirubin meters market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

The bilirubin meter is a device that measures the amount of bilirubin in a patient's blood. Bilirubin is a yellow chemical produced by the usual catabolic route in vertebrates that breaks down heme. This catabolism is essential in the body's waste removal process when old red blood cells are destroyed. The process continues as the heme is removed from the hemoglobin. Then, depending on the portion of the body where the breakdown occurs, it goes through various processes of porphyrin catabolism. The catabolic route begins with the synthesis of biliverdin from heme. The enzyme biliverdin reductase carries out the second step. Bilirubin is produced from biliverdin.

Market Dynamics

Technological advancement in Bilirubin Meters is expected to drive market growth.

In preterm and term neonates suffering from hyperbilirubinemia associated with risk factors and/or undergoing phototherapy, the newly developed non-invasive and non-contact bilirubin measurement device (AJO-Neo) as an alternative to the traditional invasive biochemical method of total serum bilirubin (TSB) estimation. The equipment was also accurate when it came to measuring bilirubin levels. The device showed impressive results with good agreement with TSB while monitoring the bilirubin level during phototherapy. The device's specificity and sensitivity demonstrated greater accuracy in neonates with associated hyperbilirubinemia risk factors. As a result, regardless of gestational or postnatal age, sex, risk factors, feeding behavior, or skin color, the newly designed gadget (AJO-Neo) is reliable in measuring bilirubin levels in preterm and term neonates. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

The high cost of the devices and Complications in the measurements of the total serum bilirubin using bilirubin meters are factors the market is expected to hamper in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 infection entails a hyperinflammatory response. Indirect bilirubin levels may be affected by increased inflammatory activity. Such intriguing associations are further investigated by examining changes in direct and indirect bilirubin levels in COVID-19 patients. Moreover, drug regimens can lead to fluctuations in bilirubin levels and lower visits to hospitals and clinics and postponed due to the economic downturn, which hampered the market growth.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.

Segment Analysis

Transcutaneous segment is expected to hold the largest market share in bilirubin meters market

The transcutaneous segment is expected to dominate in 2021. The segment benefits because these gadgets are non-invasive, accurate, cost-effective, and time-saving. Moreover, transcutaneous devices are used to screen jaundice in newborn babies without a needle prick, and they are becoming more popular as an alternative to serum bilirubin analyzers. For instance, BiliChek is utilized with skin pigmentation in jaundice, notwithstanding JM 103. TcB and total serum bilirubin (TSB) levels in African-American newborns differ. Color-coded scales were rarely used for comparison, and the codes varied greatly depending on ethnicity and race. The transcutaneous bilirubinometer index (TcBI) result is more trustworthy in babies with lighter skin than babies with darker skin. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Geographical Analysis

North America region holds the largest market share in the global bilirubin meters market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of liver diseases, the rising geriatric population, rising healthcare spending, well-established infrastructure, and technological advancement in the bilirubin meters are factors the market is expected to boost in the forecast period. For instance, it is estimated that about 1 in 400 adults in the United States has cirrhosis. Cirrhosis is more common in adults ages 45 to 54. About 1 in 200 adults' ages 45 to 54 in the United States has cirrhosis.

Moreover, More than 80 million Americans have this deadly disease, and many don't even know it. Nonalcoholic fatty liver disease affects an estimated 80 million to 100 million Americans. Therefore, it has increased the demand for the bilirubin meters. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the bilirubin meters market are: Koninklijke Philips N.V., Siemens Healthineers AG, Dragerwerk AG Co. KGaA , Mennen Medical Ltd , Natus Medical Incorporated, Avi healthcare Pvt. Ltd., Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zhengzhou Dison Instrument And Meter Co., Ltd, Delta Medical International Ltd

Koninklijke Philips N.V.:

Overview:

Koninklijke Philips N.V. is a Dutch multinational conglomerate corporation. Philips was formerly one of the largest electronics companies globally, currently focused on health technology, with other divisions being divested. Philips is organized into three main divisions: Personal Health (formerly Philips Consumer Electronics and Philips Domestic Appliances and Personal Care), Connected Care, and Diagnosis & Treatment (formerly Philips Medical Systems). It currently employs around 80,000 people across 100 countries.

­Product Portfolio:

BiliChek System: The BiliChek noninvasive, transcutaneous bilirubinometer assesses the risk of hyperbilirubinemia (newborn baby jaundice) in newborns. Using light instead of a needle, it allows you to easily measure serum bilirubin levels.

Why Purchase the Report?

  • Visualize the composition of the bilirubin meters market segmentation by product type, age group, indication, end user and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in bilirubin meters market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of bilirubin meters market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global bilirubin meters market report would provide an access to an approx. 45+ market data table, 40+ figures and 160 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Age Group
  • 3.3. Market Snippet by Indication
  • 3.4. Market Snippet by End user
  • 3.5. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancement in Bilirubin Meters is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of the devices is expected to hamper in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Bench-top
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Transcutaneous
  • 7.4. Others

8. By Age Group

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age Group
    • 8.1.2. Market Attractiveness Index, By Age Group Segment
  • 8.2. Neonates*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Adults
  • 8.4. Others

9. By Indication

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 9.1.2. Market Attractiveness Index, By Indication Segment
  • 9.2. Hepatitis*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Jaundice
  • 9.4. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinics
  • 10.4. Diagnostic Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age Group
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age Group
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age Group
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age Group
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age Group
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Koninklijke Philips N.V.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Siemens Healthineers AG
  • 13.3. Dragerwerk AG Co. KGaA
  • 13.4. Mennen Medical Ltd
  • 13.5. Natus Medical Incorporated
  • 13.6. Avi healthcare Pvt. Ltd.
  • 13.7. Ningbo David Medical Device Co. Ltd.
  • 13.8. Micro Lab Instruments
  • 13.9. Zhengzhou Dison Instrument And Meter Co., Ltd
  • 13.10. Delta Medical International Ltd

LIST NOT EXHAUSTIVE

14. Global Bilirubin Meters Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us